In melanoma, CBL0137 can reverse the resistance to ICB therapy.287 These findings could reveal potential strategies for combating immunotherapy resistance and inhibiting ADAR1 may cause tumors to transition from an immunologically cold to an immunologically hot state (Fig. 5). This evidence concerns the gene ADAR and melanoma.